Abeona Stands to Collect Royalties After Ultragenyx's FDA Approval — Here's the Rest of the Week

US FDA approves Ultragenyx's gene therapy for rare disorder

QUICK SPARK: Pharma Bro Martin Shkreli Says Ultragenyx Should Be M&A Target

Ultragenyx Forced To Cut Costs After Disappointing Phase 3 Results

Ultragenyx Stock Sinks 47% on Drug Trial Failure. Why Wall Street Isn't Giving Up Yet.

Ultragenyx shares crater after Angelman syndrome drug fails late-stage trial

Ultragenyx's rare disease drug fails in late-stage trial; shares plunge

Ultragenyx Nabs FDA Nod for First Gene Therapy

Ultragenyx's gene therapy for rare metabolic disorder secures US FDA nod